Biotechnology

GlaxoSmithKline announced today that it is waiving a condition relating to a pending lawsuit in the previously announced tender offer to purchase all of the outstanding shares of common stock of Genelabs Technologies, Inc. , for $1.30 per share in cash w

- Product Extremely Well Tolerated -

InnoCentive, Inc., the global innovation marketplace, and The Global Alliance for TB Drug Development , a not-for-profit, product development partnership dedicated to accelerating the discovery and development of new Tuberculosis drugs, today announced t

Sigma-Aldrich and SouthWest NanoTechnologies Inc. , a leading producer of single-wall carbon nanotubes, announced today that they have signed an agreement under which Sigma-Aldrich will distribute SWeNT's single-wall carbon nanotubes to the research and

Cytokinetics, Incorporated announced today that Sharon Barbari, Senior Vice President, Finance and Chief Financial Officer, is scheduled to participate in a panel discussion entitled 'Replacing The Mainstay With Newer And Better Agents' at the RBC Capita

a stent system that has not had any stent thrombosis in clinical studies. It is CE Marked and available for purchase throughoutEurope and now some Middle Eastern countries with aggressive world-wide expansion ongoing. Concurrently, CeloNova notes that it

Cellectricon, a leading provider of screening solutions for drug discovery, today announced the signing of a collaborative agreement with The Automation Partnership in the UK, manufacturers of advanced automated systems for cell culture, sample managemen

Aceto Corporation (ACET) Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell